Regulation of the cholesterol side-chain cleavage cytochrome P-450 and adrenodoxin mRNAs in cultured choriocarcinoma cells

Mol Cell Endocrinol. 1992 Apr;84(3):195-202. doi: 10.1016/0303-7207(92)90030-a.

Abstract

Cytochrome P-450scc (P-450scc) catalyzes the cholesterol side-chain cleavage reaction, a rate-limiting enzymatic step for progesterone synthesis in trophoblastic and other steroidogenic cells. Adrenodoxin is the iron/sulfur protein donating electrons to P-450scc during this reaction. We examined the effects of cholera toxin (CT), an activator of adenylate cyclase, and 12-O-tetradecanoylphorbol acetate (TPA), a phorbol ester protein kinase C activator, on the levels of mRNAs encoding P-450scc and adrenodoxin in JEG-3 choriocarcinoma cells. CT induced in a concentration- and time-dependent manner P-450scc and adrenodoxin mRNA levels to 8-fold and 1.5-fold above that of control, respectively. TPA also increased P-450scc and adrenodoxin mRNA levels about 3-fold and 1.5-fold above that of control, respectively. Epidermal growth factor (EGF) was found to weakly induce P-450scc mRNA accumulation with a maximal 20% stimulation above basal levels. The effects of CT and TPA were apparently additive on both mRNAs. The protein synthesis inhibitor cycloheximide diminished basal, CT-, TPA-, and EGF-stimulated P-450scc mRNA accumulation whereas the opposite was observed for the adrenodoxin mRNA. Insulin-like growth factor I (IGF-I) appeared to have no effect on either mRNA. These data indicate that: (1) the accumulation of P-450scc and adrenodoxin mRNAs is mainly controlled by the cyclic adenosine 3',5'-monophosphate (cAMP)-dependent pathway but their stimulation by TPA- and EGF-induced signals may also play a weaker synergistic role; (2) the protein synthesis inhibitor cycloheximide inhibits basal, CT-, TPA- and EGF-stimulated P-450scc mRNA levels while it increases the expression of adrenodoxin mRNA suggesting that in the malignant trophoblasts these two enzyme mRNAs are differentially controlled.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenodoxin / biosynthesis*
  • Adrenodoxin / genetics
  • Analysis of Variance
  • Blotting, Northern
  • Cholera Toxin / pharmacology
  • Cholesterol / metabolism
  • Cholesterol Side-Chain Cleavage Enzyme / biosynthesis*
  • Cholesterol Side-Chain Cleavage Enzyme / genetics
  • Choriocarcinoma / metabolism
  • Cyclic AMP / metabolism
  • Cycloheximide / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • Nucleic Acid Hybridization
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Cells, Cultured

Substances

  • RNA, Messenger
  • Adrenodoxin
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I
  • Cholera Toxin
  • Cholesterol
  • Cycloheximide
  • Cyclic AMP
  • Cholesterol Side-Chain Cleavage Enzyme
  • Tetradecanoylphorbol Acetate